Pennington, NJ, United States of America

Eric M Gordon

USPTO Granted Patents = 100 

 


Average Co-Inventor Count = 2.1

ph-index = 16

Forward Citations = 1,013(Granted Patents)


Inventors with similar research interests:


Location History:

  • West Trenton, NJ (US) (1978 - 1983)
  • Pennington, NJ (US) (1979 - 2000)
  • Palo alto, CA (US) (1994 - 2023)

Company Filing History:


Years Active: 1978-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aztreonam Derivatives
Beta-Lactamase Inhibitors
Oxazolidinone Libraries
Protease Inhibitors
HMG-CoA Reductase Inhibitors
Mevinic Acid Derivatives
Hydroxamic Acid Derivatives
Aminediol Inhibitors
Enkephalinase Inhibitors
Analgesic Agents
Ureido Amino Acids
Combinatorial Libraries
100 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric M. Gordon

Introduction: Eric M. Gordon is a distinguished inventor based in Pennington, NJ, renowned for his extensive contributions to the field of pharmacology, boasting a remarkable portfolio of 100 patents. His innovative work focuses on developing new therapeutic methods and pharmaceutical compositions, showcasing a deep commitment to medical advancements.

Latest Patents: Among his latest patents are groundbreaking methods of synthesizing aztreonam derivatives. These comprise not only novel therapeutic methods for administering these derivatives but also effective synthesis techniques for creating orally bioavailable aztreonam. Another significant advancement is the patent covering derivatives of relebactam, which highlights their therapeutic application, especially in combination with β-lactam antibiotics. The focus on oral administration for these derivatives underscores his dedication to enhancing patient accessibility to essential medications.

Career Highlights: Eric M. Gordon has built a notable career in research and development, working with reputable companies such as E.R. Squibb & Sons, Inc. and Arixa Pharmaceuticals, Inc. His work at these firms has significantly impacted the pharmaceutical landscape, particularly in antibiotic development.

Collaborations: Throughout his career, Eric has collaborated with esteemed colleagues, including Ravi K. Varma and Harold N. Weller, III. These partnerships have fostered a dynamic exchange of ideas, leading to innovative solutions in drug formulation and therapeutic applications.

Conclusion: Eric M. Gordon's impressive body of work and commitment to innovation in pharmaceuticals exemplify the crucial role of patenting in the advancement of medical science. His patents, particularly in synthesizing aztreonam and relebactam derivatives, highlight his impact on future therapeutic pathways, ensuring that new medications will continue to be developed for better patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…